Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1149 results about "Drug administration" patented technology

The U.S. Food and Drug Administration (FDA) is the government agency responsible for reviewing, approving and regulating medical products, including pharmaceutical drugs and medical devices. It also regulates various other products, including food, cosmetics, veterinary drugs, radiation-emitting products, biological products and tobacco.

Individual mutation information-based intelligent decision-making system for precise targeted medication of tumors

The invention relates to the technical field of tumor treatment, in particular to an intelligent decision-making system for tumor precise targeted medication based on individual mutation information, which comprises a data processing layer, a variation annotation and function prediction layer, a knowledge base integration layer and a scheme decision-making engine and report visualization module. According to the intelligent decision-making system for tumor precise targeted medication based on individual mutation information, a rule engine and a prediction model are combined, dynamic priority ranking is output, multi-model fusion decision making is achieved, and clinical scene deep adaptation is achieved by predicting primary and secondary drug resistance, calculating liver and kidney function adjusting dosage and generating a combined medication time sequence scheme; through an individualized drug delivery scheme, combination drug use optimization is achieved, a visual clinical report is generated, clinical executable operation is further strengthened, and through algorithm quantification, a dynamic knowledge graph, AI auxiliary decision making and a clinical operation closed loop, the next-generation technical research direction of a tumor precise drug use system can be represented.
Owner:BEIJING BIOMASION TECH

Nursing pressure real-time monitoring system and method based on multi-modal data

The invention discloses a nursing pressure real-time monitoring system and method based on multi-modal data. The system comprises a data acquisition module, an intelligent analysis module, an analysis module and a real-time feedback module. The data acquisition module synchronously acquires physiological data, behavior activity data and environment situation data of nursing personnel and forms a nursing signal; the analysis module receives the nursing signal from the data acquisition module, receives the dynamic situation information from the intelligent analysis module, and generates a pressure state signal containing pressure event evaluation; the real-time feedback module receives the pressure state signal containing the pressure event evaluation from the analysis module, and generates and outputs a real-time feedback signal based on the pressure state signal. According to the nursing pressure real-time monitoring system and method based on the multi-modal data, the problem that traditional wearable equipment only collects physiological behavior data and cannot be associated with specific nursing situations such as drug administration operation and patient first aid can be solved.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Wearable device for patient monitoring and drug administration

A modular disease management system may provide medication management for a patient. The system may include a base configured to at least partially couple to a tissue site of a patient. The system may further include a medication bladder coupled to the base and configured to maintain medication. The system may further include a medication pump coupled to the medication bladder, comprising a conduit and muscle wire-actuated plungers, wherein the medication pump is configured to cause the medication to flow from the medication bladder through the conduit. The system may further include a cannula insertion device coupled to the medication pump via the conduit, wherein the cannula insertion device comprises a cannula, a spring, and a triggering component, wherein the cannula insertion device is configured to insert the cannula into the tissue site of the patient by actuation of the spring released by the triggering component.
Owner:WILLOW LAB INC

Microneedle drug administration apparatus and preparation method therefor

The present disclosure relates to the technical field of drug delivery, and in particular, to a microneedle drug administration apparatus and a preparation method therefor. The apparatus comprises substrates, microneedle arrays, and a liquid-absorbing swelling material. Each substrate carries a microneedle array, and the liquid-absorbing swelling material is placed between the substrates to form a sandwich structure. The apparatus uses a mild water absorption and swelling mechanism and the natural peristaltic behavior of the gastrointestinal tract to pierce the intestinal wall using the microneedles to complete drug delivery. The present disclosure physically breaks through the physiological barrier of oral delivery and absorption of biological drugs, improving the oral availability of biological drugs. All materials used are biodegradable soft materials, which are highly safe.
Owner:TSINGHUA UNIVERSITY

Apparatuses, systems, and methods for aerosolized drug administration

PCT designated stage expiredWO2025083212A1Medical devicesMedical atomisersDrug administrationSurgery
A system for delivering an aerosolized drug to a patient. The system includes a holding chamber (108), suitable to contain a drug to be aerosolized, and a connect element (100) having first and second ends, the second end being opposite to the first end and being suitable to be connected to the holding chamber (108). The connect element further comprises one or more mating mechanism (102, 104, 112, 114, 118) proximal its first end. The system can also include a mouthpiece (400), a drug assembly (200) including a drug housing (216) and a drug cartridge (300), and a vaporizer (500).
Owner:GH RES IRELAND LTD

Postoperative illness condition monitoring device for anorectal patient in traditional Chinese medicine

The invention discloses a postoperative illness condition monitoring device for a patient in the anorectal department of traditional Chinese medicine, and relates to the technical field of postoperative nursing, the postoperative illness condition monitoring device comprises a drug administration monitoring device and an illness condition monitoring system, and the drug administration monitoring device comprises a drug administration barrel and a retention part; the illness state monitoring system comprises a sensor integration unit, an abnormity analysis unit, an alarm prompting unit and a drug administration suggestion unit; various post-operation data information of a patient is collected through the sensor integration unit, abnormity reminding signals are generated after abnormity judgment is carried out on the different data information, the patient and family members of the patient are reminded through the prompter arranged in a ward, meanwhile, reminding is sent to the remote medical terminal in a nurse station through the remote transmission module, and the patient is reminded through the remote transmission module. And the corresponding nursing suggestions are output to the remote medical terminal in the nurse station or the mobile terminal of the patient, so that the effect of monitoring the postoperative illness state in real time is achieved, negligence of manual observation is avoided, the corresponding suggestions can be quickly given, and effective measures are provided for medical staff and the patient.
Owner:XIN HUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Anesthesia strategy generation system fusing time sequence data and knowledge graph

The invention discloses an anesthesia strategy generation system fusing time sequence data and a knowledge graph, and relates to the technical field of medical information processing. The method specifically comprises the steps that five types of vital sign data including arterial blood pressure, electrocardio and electroencephalogram are collected, correction is conducted in combination with traction marks and electrotome interference characteristics, and an analysis result is output; the inference analysis module executes double-track processing based on the analysis value, one track evaluates cortical suppression, shock and ventilation risks and generates a risk report, and the other track performs reverse arbitration when the blood oxygen data is abnormal; constructing a knowledge graph fusing the efficacy nonlinear cooperation equation, the age sensitive parameters and the drug administration sequence influence; and the strategy generation module integrates the multi-source data to generate a drug execution track, and executes fast and slow closed-loop regulation and control based on a risk report and an arbitration result. According to the invention, the adaptation capability of the system to individual differences, the abnormal signal identification and processing capability and the intelligent response level of the anesthesia strategy are improved, and the accuracy and safety of clinical anesthesia are significantly enhanced.
Owner:SHANGHAI YANGZHI REHABILITATION HOSPITAL

Clinical pharmacy intelligent management method and system and storage medium

The invention relates to the technical field of pharmacy management, in particular to a clinical pharmacy intelligent management method and system and a storage medium. The method comprises the following steps: acquiring total element data of a drug treatment chain in real time, wherein the total element data comprises a prescription instruction stream, a drug preparation parameter, a drug administration execution record and a patient physiological feedback signal; constructing a drug treatment chain dynamic evaluation engine; establishing a digital twinning mapping relationship between the administration operation and the clinical terminal for the total element data of the drug treatment chain by utilizing a drug treatment chain dynamic evaluation engine, and generating a drug digital relationship chain; and performing drug treatment chain breakage risk point identification on the drug digital relation chain based on a multi-dimensional deviation detection algorithm to obtain drug treatment abnormal risk points. Through real-time data acquisition, digital twinborn mapping and intelligent risk identification and intervention, intelligent management and accurate regulation and control of the drug treatment chain are improved, and intelligence and accuracy of drug treatment chain management are improved.
Owner:THE 971ST HOSPITAL OF THE CHINESE PEOPLES LIBERATION ARMY NAVY

Step-by-step targeted placenta trophoblast micro-nano robot as well as preparation method and application thereof

PendingCN120037406AAntipyreticAnalgesicsCells/microLTrophoblast
The invention discloses a step-by-step targeting placenta trophoblast micro-nano robot as well as a preparation method and application thereof. The micro-nano robot comprises a yeast cell wall of a bag-shaped structure, bio-enzyme unevenly distributed on the surface of the yeast cell wall and targeted placenta trophoblast drug-loaded nanoparticles located in the yeast cell wall. The surfaces of the targeted placenta trophoblast drug-loaded nanoparticles are connected with placenta-like chondroitin sulfate A binding polypeptides. Inflammation placenta tissue can be targeted through macrophages, the medicine is accurately delivered to placenta trophoblastic cells through the medicine-carrying nano-particles connected with the targeting peptide, step-by-step accurate targeting is achieved, the medicine does not penetrate through the placenta barrier to reach the body of a fetus, and high biological safety is achieved for pregnancy administration.
Owner:THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY

Correlation of AKR1c3 enzyme expression level with KRAS mutation, and medical use

Correlation of the AKR1C3 enzyme expression level with KRAS mutation, and a medical use. For an AKR1C3 enzyme activated anti-cancer prodrug, KRAS gene mutation can directly serve as a test target before drug administration, that is, a patient with KRAS mutation is the patient having a high AKR1C3 enzyme expression level and AKR1C3 enzyme expression level or AKR1C3 RNA testing is not required. That is to say, a positive KRAS mutation testing result can be used as a screening index to screen the patient having a high AKR1C3 enzyme expression level.
Owner:SHENZHEN ASCENTAWITS PHARM TECH CO LTD

Tree shrew Alzheimer's disease modeling method

The invention discloses a tree shrew Alzheimer's disease modeling method. The method comprises the following specific steps: mixing an ethanol solution of Microcystin-LR with the concentration of 0.5 [mu] g / [mu] l with an amaninic acid solution, and injecting 2 [mu] l to Meynert basal nuclei on the two sides of a tree shrew respectively; and after drug administration is finished, normally feeding for 2 weeks to finish Alzheimer's disease modeling. The method comprises the following steps: under a sterile condition, sucking 200 microliters of sterile normal saline, adding the sterile normal saline into a small bottle containing 1mg of amanitine, repeatedly blowing and beating to completely dissolve the amanitine, and preparing a solution with the concentration of 5mu g / microliter; the Microcystin-LR solution is a product purchased in the market. According to the invention, a mixed solution of MC-LR (0.1 [mu] g) and IBO solution (3 [mu] g) is respectively injected to Meynert basal nuclei on both sides of the tree shrew, and a stable tree shrew AD model can be established after 2 weeks. After the medicine is administrated for 3 days, tree shrews have AD behavior expressions, such as drooping spirit and reduced activity; after two weeks, the tree shrew brain shows AD typical pathological expressions such as A beta deposition, increase of expression levels of multiple phosphorylation sites of Tau protein and the like.
Owner:LABREAL BIOTECH KUNMING CO LTD +1

Intelligent bandage integrating wound monitoring, drug administration and electrical stimulation

The invention discloses an intelligent bandage integrating wound monitoring, drug administration and electrical stimulation. The intelligent bandage comprises a bandage body, a portable battery, a wound monitoring module, an intelligent drug administration module, an electrical stimulation module and a portable control module. The bandage body is of a double-layer structure, the inner layer is an antibacterial fiber layer, and the outer layer is a breathable waterproof layer. By means of the design, the wound can be kept dry, and external bacteria can be prevented from invading. The bandage body is further provided with a bandage elastic area which is used for adjusting the tightness of the bandage so as to meet the requirements of different wound parts. 3-6 sensors are arranged on the inner surface of the bandage body and used for monitoring key physiological indexes of a wound in real time, and accurate information is provided for treatment. The intelligent drug delivery module adopts a drug-loaded stimuli-responsive electroactive hydrogel fiber array and is arranged on the inner surface of the bandage body, and accurate drug delivery is achieved through a voltage modulation electrode. The electrical stimulation module adopts a pseudo convergence electric field configuration, is arranged on the inner surface of the bandage body, and is switched between the electrical stimulation electrodes through a timing relay so as to alternately push the wound to be closed. The portable battery supplies power to the portable control module, and the portable control module comprises an integrated microprocessor module, a wireless communication module and a lumped power management module and is connected with the intelligent drug delivery module, the wound monitoring module and the electrical stimulation module to achieve remote monitoring and personalized treatment.
Owner:SHAOXING ZHIBOKANG TECHNOLOGY CO LTD

Precise medication system for hemodialysis patient based on multiple omics and big data

The invention relates to the technical field of medical care informatics and precision medical treatment, and discloses a hemodialysis patient precision medication system based on multiple omics and big data, and the system comprises a multi-source data collection module which collects the multi-source heterogeneous data of a patient and carries out the standardization and integration processing; the drug metabolism analysis module is used for analyzing drug metabolism paths and individual differences through multi-omics data, constructing a drug metabolism polymorphic model and outputting gene metabolism capability grades and biomarker risk tags; the initial medication decision-making module is used for constructing an initial medication decision-making model based on a federal optimization framework of a momentum enhancement and robust aggregation mechanism, and outputting a personalized initial medication scheme for erythropoietin and a vein iron agent; and the drug dosage adjustment module is used for dynamically optimizing the time node and dosage adjustment opportunity of drug administration through an asynchronous federal reinforcement learning framework in combination with a prospective parameter correction strategy. According to the invention, the intelligent medication system with strong robustness and fine decision is constructed.
Owner:YUQING HEMODIALYSIS SERVICE MANAGEMENT GRP CO LTD

Metal polyphenol network modified drug-loaded radioactive microsphere as well as preparation method and application thereof

The invention discloses a metal polyphenol network modified drug-loaded radioactive microsphere as well as a preparation method and application thereof, radionuclides are labeled on different microspheres by a precipitation method or an adsorption method, and the metal polyphenol network is modified on the surface of the radioactive microsphere to improve the nuclide labeling stability and the synchronous drug loading capability of the radioactive microsphere. Subsequently, medicine molecules can be adsorbed to the modified radioactive microspheres to obtain the metal polyphenol network modified medicine-carrying radioactive microspheres. The metal polyphenol network modified drug-loaded radioactive microspheres prepared by the invention can solve the problems of radionuclide non-target shedding and DNA damage repair caused by nuclear drugs, avoid secondary drug administration, ensure that drugs directly and accurately reach tumor targets, and improve the drug delivery efficiency. And the selective internal irradiation therapy based on radioactive microsphere mediation is further promoted to play a more effective tumor treatment effect.
Owner:SUZHOU UNIV

Automatic drug delivery system for first aid of hypoglycemic patient

The invention relates to the technical field of medical care informatics, in particular to an automatic drug delivery system for first aid of hypoglycemia patients, comprising: a data acquisition module for acquiring a blood glucose level curve and an acceleration monitoring curve; the evaluation value determination module is used for determining a second evaluation value in an unconscious faint state according to the blood glucose level curve and the acceleration monitoring curve; the intensity value determining module is used for determining the first-aid intensity value of the hypoglycemia patient according to the second evaluation value and the target curve segment of the acceleration monitoring curve; the first-aid operation module is used for providing first-aid operation of the corresponding level for the hypoglycemia patient through the first-aid intensity value. According to the invention, the first-aid intensity value is determined, so that the drug delivery system for first aid makes the corresponding response operation, and the first-aid effect of the hypoglycemia patient is improved.
Owner:YOUAN TECHNOLOGY (NANTONG) CO LTD

Hand-held dosing device for anorectal department

The utility model discloses an anorectal department hand-held dosing device relates to hand-held dosing ware technical field, including applying tube and dosing tube, applying tube is located in the dosing tube, the arc surface of dosing tube is fixedly connected with support plate, the upper surface of support plate is threadedly penetrated with screw, the lower end of screw is rotatingly connected with connecting plate, and the connecting plate is connected with the connecting plate. The lower surface of the connecting plate is uniformly and fixedly connected with two pressing rods, the arc surface of the dosing tube is fixedly connected with two T-shaped rods, the arc surfaces of the T-shaped rods are rotatably connected with two circular tubes, the arc surfaces of the two circular tubes are fixedly connected with an L-shaped plate, and the pressing rods are located on one side of the L-shaped plate. The effect of supporting the buttocks of the patient in the anus dosing process of the anorectal patient is achieved, and the problems that the exposed position of the anus is small when the buttocks are supported with one hand for dosing, multiple persons need to operate at the same time when the buttocks are supported with two hands, and the overall tedious process is improved are solved.
Owner:CHONGQING TRADITIONAL CHINESE MEDICINE HOSPITAL

Minoxidil film coating agent as well as preparation method and application thereof

The invention relates to the technical field of pharmaceutical preparations, and provides a minoxidil film coating agent as well as a preparation method and application thereof. The minoxidil film coating agent provided by the invention comprises 40-60% of propylene glycol, 3-7% of polyvinyl alcohol, 20-30% of ethanol, 1-7% of minoxidil and the balance of water. According to the invention, propylene glycol is taken as a solvent, a plasticizer and a transdermal absorption enhancer, polyvinyl alcohol is taken as a film-forming material, and ethanol is taken as a volatile agent, after administration, ethanol is volatilized to promote film formation of polyvinyl alcohol, and propylene glycol enhances the plasticity of the formed film, so that the effect of reducing liquid medicine loss is achieved, the local medicine concentration is increased, and the bioavailability is improved. The minoxidil liniment disclosed by the invention has excellent skin permeability, can effectively convey a medicine to a required part, and can ensure that the medicine is released at a fixed position of the skin and is accurately administered in a medicine release process, so that the stimulation of liquid medicine flow to other parts is reduced, and a good treatment effect is achieved.
Owner:SHANDONG INOMIC INST OF PHARM RES CO LTD

Disposable transanal dosing device

The utility model relates to a disposable transanal drug delivery device, which comprises a hose with a drug outlet micropore at the front end, and is characterized by further comprising a hard outer tube, a push rod and a hard support rod, the hard outer tube is of a double-layer jacket structure with an opening at the rear end, a jacket cavity is arranged in the hard outer tube, lubricant is filled in the jacket cavity, and the hard support rod is connected with the push rod. The push rod is inserted into the jacket cavity of the hard outer pipe from the rear end opening, small holes are uniformly distributed in the surface of an outer layer shell of the hard outer pipe, and a detachable covering film is arranged on the surface of the hard outer pipe; the hose is arranged in a center channel of the hard outer pipe, the hard supporting rod coaxially penetrates through the hose, and the front end of the hard supporting rod abuts against the inner wall of the front end of the hose. The anus dilator is ingenious in structure and reasonable in design, the hard outer tube is used for dilating the anus so that the hose can smoothly enter the anus, and dosing can be conveniently conducted through the hose.
Owner:GENERAL HOSPITAL OF NUCLEAR IND

Controllable flexible pressing device applied to microneedle patch skin surface drug delivery

The utility model discloses a controllable flexible pressing device applied to microneedle patch skin surface drug delivery, and belongs to the technical field of drug delivery, the controllable flexible pressing device comprises a microneedle patch, an electrostatic adsorption membrane, a rigid support body, an air bag and a thin film pressure sensor, the microneedle patch is attached to the skin surface, and a needle head is downward; the electrostatic adsorption membrane is arranged above the microneedle patch; the rigid support body is arranged on the electrostatic adsorption membrane, and an air bag mounting cavity is formed in the middle of the rigid support body; the air bag is arranged in the air bag mounting cavity; and the thin film pressure sensor covers the air bag. The device is simple in structure and convenient to operate, the application direction, the change rate, the magnitude and the action time of force in the dosing process can be controlled, the penetration depth of the microneedle is influenced, and then the positive influence on the experimental result and the clinical effect is generated.
Owner:NANTONG WEIZHEN PHARM TECH CO LTD

Anesthesia depth self-adaptive regulation and control method and system based on dynamic time sequence model

The invention belongs to the technical field of anesthesia depth regulation and control, and particularly relates to an anesthesia depth self-adaptive regulation and control method and system based on a dynamic time sequence model, and the system comprises a portable computer which is used for operating a program, receiving electroencephalogram time sequence data output by a signal collection device, receiving a pressing event of a handle, and obtaining efficacy information of an effect part; a channel gating result is generated based on the information and used for conducting category division on a drug administration adjustment request, gating is conducted through a shared code LSTM and a two-channel LSTM head and an effect room concentration vector and a hysteresis band, the problem of rhythm dislocation caused by exponential smoothing lag and induction-waking asymmetry is solved, mistaken up-regulation or mistaken down-regulation and overshoot are reduced, and the accuracy of drug administration adjustment is improved. And the adjustment convergence time is shortened, so that the anesthesia depth is more stably maintained in a target interval.
Owner:BEIJING STOMATOLOGY HOSPITAL CAPITAL MEDICAL UNIV

Microneedle real-time imaging and drug delivery system

A microneedle real-time imaging and drug delivery system comprises a microneedle array disc module used for releasing drugs into a living body and collecting real-time response electrical signals; an excitation power supply module, a signal processing module and a control module; the excitation power supply module is used for receiving an instruction sent by the control module and providing an excitation electric signal for the microneedle array disc module according to the instruction; the signal processing module is used for preprocessing the real-time response electrical signal; the control module is used for carrying out secondary processing on the preprocessing result; the data transmission module is used for transmitting the secondary processing result output by the control module to the upper computer module; and the upper computer module is used for receiving and deeply processing the secondary processing result. According to the invention, the monitored real-time response electrical signal is processed to generate an image, so that a user can observe related conditions of biological subcutaneous tissues in real time, and a better drug administration effect is achieved.
Owner:GUANGDONG UNIV OF TECH

Transdermal drug delivery controlled release disc and transdermal drug delivery equipment

The utility model relates to the technical field of medical equipment, and discloses a transdermal drug delivery controlled release disc and a transdermal drug delivery device.The controlled release disc comprises a disc body, a central drug delivery cavity and an annular negative pressure adsorption cavity are formed in the disc body, and the negative pressure adsorption cavity is located on the outer side of the central drug delivery cavity; the inner top end of the negative-pressure adsorption cavity is provided with at least one convex rib, the upper space of the negative-pressure adsorption cavity is divided into at least two adsorption areas through the convex ribs, the adsorption areas are distributed in the radial direction of the disc body, and the negative-pressure adsorption cavity is provided with negative-pressure openings communicated with the adsorption areas; the negative pressure adsorption cavity is arranged to enable the skin to be stretched to the adsorption area under the negative pressure effect and to be attached to the surface of the adsorption area. According to the transdermal drug delivery controlled release disc, the technical effects of improving the adsorption stability of the disc body on the skin and reducing the possibility that the disc body falls off from the skin are realized, and the problem that the transdermal drug delivery controlled release disc is easy to fall off when being adsorbed and fixed on the skin in the related technology is solved.
Owner:HUAXIA CHENGHUANG (BEIJING) HEALTH TECH CO LTD

Post-craniotomy subcutaneous effusion puncture suction and administration device

ActiveCN119345490AInfusion syringesInfusion needlesDrug administrationPerioperative management
The invention relates to the technical field of perioperative period management, and provides a post-craniotomy subcutaneous effusion puncture suction and administration device which comprises a lantern ring, a plurality of fixing sleeves are fixedly connected to the inner circumference of the lantern ring and surround the inner circumference of the lantern ring at equal intervals, an expansion air bag is fixedly arranged in each fixing sleeve in a sleeved mode, and the expansion air bags are fixed to the inner circumference of the lantern ring in a sleeved mode. Cotton gaskets are arranged on the inner peripheries of the multiple fixing sleeves, and the expansion air bag enables the cotton gaskets to abut against the forehead of the patient through expansion so that the lantern ring can be fixed to the forehead of the patient. The two traction arcs are arranged in a crossed and staggered mode, sliding grooves are formed in the middle ends of the traction arcs, and an expansion fixing piece is connected to the intersection of the two sliding grooves in a sliding mode. The device can be matched with a single person to carry out subcutaneous hydrops suction and medicine injection work after craniotomy, in the suction or medicine injection process, the device assists in fixing a needle head and carrying out syringe operation with two hands, multiple persons do not need to carry out stable hydrops suction and medicine injection operation, medical convenience is improved, and manpower consumption is reduced.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Genetically engineered exosome as well as slow release method and application thereof

The invention discloses a gene engineering exosome and a slow release method and application thereof, the gene engineering exosome is derived from human adipose-derived stem cells, si-tgfbr2 is loaded in the gene engineering exosome, the si-tgfbr2 is specific siRNA aiming at a Tgfbr2 gene, and the gene engineering exosome can regulate and control proliferation of VSMCs, inhibit transformation of the VSMCs from a contraction phenotype to a synthetic phenotype when the VSMCs are stimulated, and inhibit the growth of the VSMCs. According to the present invention, the gene engineering exosome can be used to maintain the normal structure and the function of the blood vessel, and the sustained release effect of the content in the gene engineering exosome can be achieved by wrapping the gene engineering exosome in the PHA biodegradable material, such that the local treatment concentration can be easily stabilized, the drug administration frequency can be easily reduced, the lasting time of the treatment effect can be easily prolonged, and the treatment gene can be effectively delivered to the target cell; the treatment effect is improved; when being used for modifying a small-caliber artificial blood vessel, the small-caliber artificial blood vessel can be improved in biocompatibility and functionality, and can be prevented from being implanted into the blood vessel for remodeling unbenign hyperplasia stenosis; the invention not only provides a new thought and method for the treatment of vascular diseases, but also has important clinical application value and popularization prospect.
Owner:FUWAI HOSPITAL CHINESE ACAD OF MEDICAL SCI & PEKING UNION MEDICAL COLLEGE

Cerebral ischemia drug administration time window intelligent decision-making method

The invention discloses an intelligent decision-making method for a cerebral ischemia drug administration time window, and relates to the technical field of intelligent decision-making. The method comprises the following steps: S1, acquiring parameters, and setting a cerebral ischemia drug configuration scheme; s2, extracting a medicine characteristic parameter set and a medicine taking influence parameter set; s3, calculating a drug combination risk parameter set; s4, performing hierarchical classification processing on the drug combination risk parameter set, and performing drug correlation analysis; s5, performing weighted fusion on a correlation analysis result in combination with a drug influence attenuation rule, generating a drug administration time window evaluation parameter, and adding a label; and S6, according to the parameters, the labels and the configuration scheme, generating a cerebral ischemia drug administration time window intelligent decision scheme, and performing storage and backup. According to the method, by combining directional extraction of the drug characteristic parameter set and the drug taking influence parameter set with Pearson correlation algorithm screening, decision errors caused by data deviation are avoided.
Owner:KUNMING MEDICAL UNIVERSITY

Automatic injection pen

An automatic injection pen includes a shell, a needle cover slidably provided in the shell, an inner sleeve, a pen cap, a spring cylinder, a pen tube stopper and a syringe assembly. The syringe assembly includes a barrel, a needle and a piston assembly. The piston assembly includes a push head, a push rod, a spring support portion, a locking protrusion, a guiding portion and an actuation portion from bottom to top. An outer side of the spring support portion is provided with a spring for drug administration. The piston assembly, the spring, the spring cylinder, the needle cover, and the pen tube stopper constitute a locking-actuation mechanism. A push rod of the piston assembly is provided with an elastic protrusion structure. A linear buffer is provided between the push head and a piston in the barrel to delay the needle withdrawal.
Owner:SUZHOU SAVICRED BIOTECHNOLOGY CO LTD

Negative pressure drug delivery dynamic adjusting device for wound surface and use method of negative pressure drug delivery dynamic adjusting device

The invention discloses a negative pressure drug delivery dynamic adjusting device for a wound surface and a using method thereof, and relates to the technical field of medical instruments and equipment.The negative pressure drug delivery dynamic adjusting device comprises a machine shell, a control module, a connecting module, a negative pressure module and a drug delivery module in the wound surface are installed in the machine shell, a collecting chamber is arranged on one side of the bottom of the machine shell, and a pressure stabilizing linkage control mechanism is further arranged in the machine shell; the pressure stabilization linkage control mechanism is used for dynamic regulation and control of negative pressure and drug administration in the wound surface; the connecting module is used for uniform negative pressure of the wound surface and drug administration in the wound surface; according to the scheme, multi-mode free combination is adopted, single negative pressure / in-wound drug delivery, synchronous linkage, reverse linkage and an alternating mode are supported, the full-period requirement from acute trauma to chronic repair is met, and intelligent parameter matching is conducted, for example, through pressure-flow closed-loop feedback, when the negative pressure value rises, the drug delivery flow speed in the wound is automatically reduced, and when the negative pressure value rises, the drug delivery flow speed in the wound is automatically reduced; when wound exudate is reduced, pulse negative pressure is triggered to promote microcirculation.
Owner:THE PEOPLES HOSPITAL SHAANXI PROV

Method for efficient drug administration across the blood-brain barrier and uses thereof

A method for delivering a therapeutic agent to a human brain by delivering systemically a therapeutic agent and applying low intensity pulsed ultrasound (“LIPU”) to the brain in the presence of circulating microbubbles. The therapeutic agent is delivered prior to applying LIPU if it has a plasma half-life of ≥1 h, and the therapeutic agent is delivered after applying LIPU if it has a plasma half-life of <1 h. In a second disclosed method, a first therapeutic agent is delivered systemically, LIPU is applied to the brain in the presence of circulating microbubbles, and a second therapeutic agent is delivered systemically. Also provided is a method for treating a brain disorder in a human by delivering a therapeutic agent systemically, administering a microbubble solution, and applying LIPU to the brain for a period of 1 min. to 30 min.
Owner:CARTHERA SAS

Anesthesia quantitative spraying equipment for anesthesiology department

The invention relates to the technical field of medical instruments, and discloses anesthesia quantitative spraying equipment for the anesthesiology department. The piston push rod is arranged in the syringe and can slide in the syringe; the injection end head is arranged at the end part of the injection cylinder and is communicated with the injection cylinder; the connecting pipe is arranged at one end of the injection end, and a spraying head is fixedly mounted at one end of the connecting pipe; the injection tube is arranged at the position, close to the injection end head, of the injection cylinder and communicates with the injection cylinder, and the anesthesia quantitative spraying equipment for the anesthesiology department has the advantages that quantification is limited through movement, and compared with the operation mode that manual pressing type equipment depends on the hand force of medical staff, the operation efficiency is greatly improved; dose deviation caused by factors such as operation experience difference and hand fatigue can be effectively avoided, it is ensured that the anesthetic dose injected every time strictly conforms to a preset value, and the consistency of the administration dose is remarkably improved.
Owner:THE FIRST AFFILIATED HOSPITAL OF HEBEI NORTH UNIV

A method, storage chip and device for efficiently evaluating the efficacy of in vitro combined drug administration

The present invention belongs to the field of drug research and development, and specifically discloses a method, storage chip and device for efficiently evaluating the efficacy of in vitro combined drug therapy. The present invention directly solves the problems of complexity and high cost of experiments and data processing in the existing drug development process by adopting an AI model and a simplified experimental mode. The AI ​​model optimizes concentration selection based on historical drug data, thereby reducing redundant concentrations and unnecessary number of experiments in the experiment, and improving the sensitivity and reliability of the evaluation. By simplifying the experimental design to single drug concentration point testing and a 3x3 combined drug matrix, the complexity and cost of the experiment are significantly reduced, while the speed of data processing and analysis is accelerated. The method disclosed in the present invention avoids excessive combined drug pre-testing by directly conducting single drug and 3x3 matrix combined drug testing, which can not only more effectively identify potential synergies between drugs, but also provide more accurate and practical data to support future clinical research.
Owner:CROWN BIOSCIENCE INC (BEIJING)